Session XIX: Presentation of Selected Abstracts on GI Cancer
SO-36: An immune-related gene expression profile predicts the efficacy of adding atezolizumab to first-line FOLFOXIRI/bevacizumab in metastatic colorectal cancer: a translational analysis of the phase II randomized AtezoTRIBE study
.jpg "Carlotta Antoniotti photo")